[5-(2-HYDROXY-INDAN-1-YLCARBAMOYL)-3,4-DIHYDROXY-2,5-[DIBENZYL-OXY]-PENTANOYL]-VALINYL-AMIDO-METHANE

(2R,3R,4R,5R)-2,5-Bis(benzyloxy)-3,4-dihydroxy-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-N′-[(2S)-3-methyl-1-(methylamino)-1-oxo-2-butanyl]hexandiamid

(2R,3R,4R,5R)-2,5-Bis(benzyloxy)-3,4-dihydroxy-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-N′-[(2S)-3-methyl-1-(methylamino)-1-oxo-2-butanyl]hexanediamide

(2R,3R,4R,5R)-2,5-Bis(benzyloxy)-3,4-dihydroxy-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-indén-1-yl]-N′-[(2S)-3-méthyl-1-(méthylamino)-1-oxo-2-butanyl]hexanediamide

[5-(2-HYDROXY-INDAN-1-YLCARBAMOYL)-3,4-DIHYDROXY-2,5-[DIBENZYL-OXY]-PENTANOYL]-VALINYL-AMIDO-METHANE

(2R,3R,4R,5R)-N-[(1S)-2-Methyl-1-(N-methylcarbamoyl)propyl]-N′-((1S,2R)-2-hydroxyindanyl)-2,5-bis(phenylmethoxy)-3,4-dihydroxyhexane-1,6-diamide

BEC

Dimer of Gag-Pol polyprotein [489-587]

Gag-Pol polyprotein

INHIBITOR BEA388

POL_HV1N5

symmetric/asymmetric inhibitor 3